Epidemiology and survival of patients with central nervous system solitary fibrous tumors: A population-based analysis
Frontiers in Oncology · 23.01.2023 · 12
DOI: 10.3389/fonc.2022.977629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 23.01.2023. Verfasst von Taikun Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, First Hospital of Jilin University, Changchun, Jilin, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The objective of this study was to determine population-based estimates of the epidemiology and prognosis of central nervous system solitary fibrous tumors (cSFTs).
Methods
We extracted the data of patients diagnosed with cSFTs between 2004 and 2018 from the Surveillance, Epidemiology, and End Results database. We analyzed the distribution of patients according to their demographic and clinical characteristics. Binary logistic regression analysis was performed to predict which patients would be diagnosed with malignant cSFT. Possible prognostic indicators were analyzed by multivariable Cox proportional hazards models.
Results
A total of 650 cases were included. The majority of patients were diagnosed at 50-59 years old, and the median age at diagnosis was 55 years. A total of 13.4% of the tumors were located in the spinal canal, and 24% of the tumors were benign. Most of the tumors were larger than 3 cm, but distant metastasis was rare. Tumor resection was the first choice of treatment for these patients, and total resection was achieved in 51.1%. Radiation therapy after surgery was also administered to 42.3% of the patients. The median survival was 57 months. Intracranial tumors and tumors with distant metastasis tended to be malignant. The results of the log-rank test showed that the patients who underwent total resection had better overall survival (OS), but the effect of radiation therapy after surgery was not significant. Conclusion cSFT is a rare and aggressive type of tumor. Tumor resection is the first choice for treatment, and radiation therapy after surgery does not improve OS. Patients older than 60 years of age who are diagnosed with intracranial tumors, malignant tumors and distant metastasis have worse OS outcomes than their counterparts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, First Hospital of Jilin University, Changchun, Jilin, China.
Zitieren
APA
Lu, T., Xu, H., Dong, X., Jin, Z., & Wang, Y. (2023). Epidemiology and survival of patients with central nervous system solitary fibrous tumors: A population-based analysis. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.977629
Vancouver
Lu T, Xu H, Dong X, Jin Z, Wang Y. Epidemiology and survival of patients with central nervous system solitary fibrous tumors: A population-based analysis. Frontiers in Oncology. 2023;12. doi:10.3389/fonc.2022.977629
BibTeX
@article{Lu2023,
author = {Lu, Taikun and Xu, Haiyang and Dong, Xuechao and Jin, Zheng and Wang, Yubo},
title = {Epidemiology and survival of patients with central nervous system solitary fibrous tumors: A population-based analysis},
journal = {Frontiers in Oncology},
year = {2023},
volume = {12},
doi = {10.3389/fonc.2022.977629}
}
EUVIMED